Page last updated: 2024-08-17

medroxyprogesterone acetate and Retroperitoneal Neoplasms

medroxyprogesterone acetate has been researched along with Retroperitoneal Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baltar Arias, R; Castro Ortiz, E; Fernández Salgado, E; Ibáñez Pinto, A; Ledo Barro, L; Vázquez Astray, E; Vázquez San Luis, J; Vázquez Vázquez, S1

Reviews

1 review(s) available for medroxyprogesterone acetate and Retroperitoneal Neoplasms

ArticleYear
[Gastrointestinal bleeding of obscure origin caused by a metastatic endometrial adenocarcinoma. Response to hormonal therapy].
    Gastroenterologia y hepatologia, 2007, Volume: 30, Issue:9

    Topics: Aged; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Combined Modality Therapy; Endometrial Neoplasms; Female; Gastrointestinal Hemorrhage; Humans; Lymphatic Metastasis; Medroxyprogesterone Acetate; Pelvic Neoplasms; Peritoneal Neoplasms; Retroperitoneal Neoplasms; Tomography, X-Ray Computed; Umbilicus

2007